See more : Oicintra, Inc. (OICT) Income Statement Analysis – Financial Results
Complete financial analysis of Menicon Co Ltd (MECNY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Menicon Co Ltd, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- GasLog Partners LP (GLOP-PC) Income Statement Analysis – Financial Results
- BASF SE (BAS.DE) Income Statement Analysis – Financial Results
- Nippon Carbon Co., Ltd. (5302.T) Income Statement Analysis – Financial Results
- Trigano S.A. (TRI.PA) Income Statement Analysis – Financial Results
- CANADIAN LARGE CAP LEADERS SPLI (NPS.TO) Income Statement Analysis – Financial Results
Menicon Co Ltd (MECNY)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
About Menicon Co Ltd
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 116.19B | 110.19B | 100.17B | 86.21B |
| Cost of Revenue | 55.18B | 51.72B | 47.29B | 40.39B |
| Gross Profit | 61.01B | 58.48B | 52.88B | 45.82B |
| Gross Profit Ratio | 52.51% | 53.07% | 52.79% | 53.15% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 52.06B | 46.41B | 42.92B | 37.71B |
| Operating Expenses | 52.06B | 46.41B | 42.92B | 37.71B |
| Cost & Expenses | 107.24B | 98.13B | 90.22B | 78.10B |
| Interest Income | 82.00M | 36.00M | 19.00M | 4.00M |
| Interest Expense | 571.00M | 361.00M | 332.00M | 229.00M |
| Depreciation & Amortization | 7.95B | 7.45B | 7.29B | 6.03B |
| EBITDA | 15.63B | 19.33B | 17.53B | 14.61B |
| EBITDA Ratio | 13.45% | 17.54% | 17.49% | 16.95% |
| Operating Income | 8.95B | 12.06B | 9.96B | 8.11B |
| Operating Income Ratio | 7.70% | 10.95% | 9.94% | 9.40% |
| Total Other Income/Expenses | -1.84B | -544.00M | -57.00M | 247.00M |
| Income Before Tax | 7.12B | 11.52B | 9.90B | 8.35B |
| Income Before Tax Ratio | 6.12% | 10.45% | 9.88% | 9.69% |
| Income Tax Expense | 2.57B | 4.14B | 3.42B | 2.40B |
| Net Income | 4.54B | 7.38B | 6.48B | 5.95B |
| Net Income Ratio | 3.91% | 6.69% | 6.47% | 6.90% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports